'Better Regulation' to make things worse: industry tactics to delay and weaken workplace cancer law
Corporate Europe Observatory, Brussels
Corporate Europe Observatory - Brussels
2016
27 p.
REFIT ; EU Directive ; carcinogens ; mutagens ; industry ; interest group
European Union
English
Bibliogr.
"Our new report shows how industry lobbies present employee protection against work-related cancers as an ‘unnecessary' burden on companies, and explains which tactics they use to weaken and delay the EU's revision of the Carcinogens and Mutagens Directive. In the EU alone, over 100,000 people a year die due to insufficient protection against cancer-causing substances in the workplace, which makes this lobbying a real threat to public health."
Digital
The ETUI is co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the ETUI.